Cargando…
“Just Caring”: Can We Afford the Ethical and Economic Costs of Circumventing Cancer Drug Resistance?
Personalized medicine has been presented in public and professional contexts in excessively optimistic tones. In the area of cancer what has become clear is the extraordinary heterogeneity and resilience of tumors in the face of numerous targeted therapies. This is the problem of cancer drug resista...
Autor principal: | Fleck, Leonard M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251396/ https://www.ncbi.nlm.nih.gov/pubmed/25562649 http://dx.doi.org/10.3390/jpm3030124 |
Ejemplares similares
-
Ethics roundtable: 'Open-ended ICU care: Can we afford it?'
por: Crippen, David, et al.
Publicado: (2010) -
How Can We Afford Costly Medicines?
por: Mucklow, John C
Publicado: (2000) -
Can we afford open-ended ICU care? Yes we can, but ...
por: Arnold, Klaas-Sierk, et al.
Publicado: (2010) -
So rare we need to hunt for them: reframing the ethical debate on incidental findings
por: Schuol, Sebastian, et al.
Publicado: (2015) -
P105 Robosurgeons vs. robosceptics’: can we afford robotic technology or can we afford not to?
por: Sandhu, Jasmesh
Publicado: (2021)